Suppliers / PolarisAIPharmaCorp

PolarisAIPharmaCorp

South Korea Updated 9 July 2026

PolarisAIPharmaCorp is an API manufacturer based in South Korea.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Apixaban PMDA (Japan) 1
Aripiprazole PMDA (Japan) 1
Entecavir PMDA (Japan) 1
Glimepiride PMDA (Japan) 1
オルメサルタンメドキソミル PMDA (Japan) 1
ピオグリタゾン塩酸塩 PMDA (Japan) 1
ピタバスタチンカルシウム PMDA (Japan) 1
フルボキサミンマレイン酸塩 PMDA (Japan) 1
プランルカスト水和物（製造専用） PMDA (Japan) 1
モンテルカストナトリウム PMDA (Japan) 1
Show all 15 molecules on file
レバミピド（製造専用） PMDA (Japan) 1
ロキサチジン酢酸エステル塩酸塩 PMDA (Japan) 1
Ｄｒｏｘｉｄｏｐａ PMDA (Japan) 1
Ｄｕｌｏｘｅｔｉｎｅｈｙｄｒｏｃｈｌｏｒｉｄｅ PMDA (Japan) 1
Ｅｂａｓｔｉｎｅ PMDA (Japan) 1

Also appears on these molecule pages

Glimepiride API Apixaban API Aripiprazole API Entecavir API

Questions about PolarisAIPharmaCorp

What does PolarisAIPharmaCorp make?
15 molecules are on record against PolarisAIPharmaCorp, including Apixaban, Aripiprazole, Entecavir and Glimepiride. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. PolarisAIPharmaCorp comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Alivus Life Sciences shares 1 molecule Ipca Laboratories shares 1 molecule Micro Labs shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability